Twist Bioscience and Neogene partner for next-generation personalized T cell therapies
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Join us on Monday, October 26, to learn about the role serology plays in the clinician toolbox for managing COVID-19
The DeNovix CellDrop™ Automated Cell Counter has been awarded the Gold Seal of Quality based on outstanding scientist reviews
EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need
Explore exclusive interviews, new methods, and free download to help optimize your 3D cell culture
Join us on Wednesday, October 28, to learn how SpyTag-SpyCatcher technology enables site-directed conjugation and rapid assembly of different antibody format
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
We reveal the cell counters, LC systems and particle size analyzer that have earned one of these coveted awards based on exceptional reviewer feedback
Learn how high-throughput, real-time cell analysis can accurately detect and quantify virus-neutralizing antibodies and see how this technology is advancing COVID-19 research
Find out how understanding the pathways involved in root growth inhibition can help address one of the biggest challenges in agriculture
Join us Thursday, October 22, to explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
The new products are designed to offer enhanced usability with features designed for academic, commercial, and biopharma labs to conduct basic and translational research
Join us Tuesday, October 13, to hear from the multiplexing experts behind our four-part digital pathology webinar series
Join us, Friday, October 23, to explore key technologies for sample prep, method development, and metabolomics projects in medical research